Eiger BioPharmaceuticals, Inc. Gains 27.98%

Fri, Jun 30, 2023 at 07:58 PM
Eiger BioPharmaceuticals, Inc. Gains 27.98%

Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ) rocketted at $0.7, representing a gain of 28%. The stock appeared on our News Catalysts scanner on Thu, Jun 29, 2023 at 12:04 PM in the 'MISCELLANEOUS' category. From Fri, Jun 16, 2023, the stock recorded 11.11% Up Days and 10.00% Green Days

The stock spiked on Thu, Feb 09, 2023 at $2.98 with a volume of 9M+.

About Eiger BioPharmaceuticals, Inc. (EIGR:NASDAQ)

Eiger BioPharmaceuticals Inc is a clinical stage biopharmaceutical company. It is focused on bringing to market novel product candidates for the treatment of orphan diseases.

Get Lifetime 50% Off Premium Subscription
$19.99 USD
Limited-Time Discount
$9.99 USD
Signup 7 Days Trial. No Credit Card Required!
Ever wanted to explore stocks that have recently spiked... stocks moving sideways... gaps... or other trends? You're in the right place! Check StockTreats features.